{
  "retracted": false,
  "timestamp": 1575158400000,
  "updates": [
    {
      "timestamp": 1585329773364,
      "identifier": {
        "doi": "10.1016/j.lungcan.2019.08.013"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.lungcan.2017.04.003"
  },
  "journal": "Lung Cancer",
  "publisher": "Elsevier BV",
  "title": "Erratum to “Emergence of novel and dominant acquired EGFR solvent-front mutations at Gly796 (G796S/R) together with C797S/G and L792F/H mutations in one EGFR (L858R/T790M) NSCLC patient who progressed on osimertinib” [Lung Cancer, 108 (June 2017) 228–231]"
}
